27 April 2021 (Tuesday) - Stem Cell Evidence Alert

The nice people at the Stem Cell Evidence Alert sent their update today. I won’t lie – most of it went right over my head. But one or two snippets have permeated in. And that is what CPD is (for me at least) – low level constantly updating on the hope that I learn something. After all a day when you learn nothing is a day wasted…


The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplant Outcomes: A CIBMTR Analysis. Implications During The COVID-19 Pandemic.
Hsu, J.W., et al. (2021) Transplantation and Cellular Therapy [record in progress]. 



Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
Bento, L., et al. (2021) Bone Marrow Transplantation

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide.
DeZern A. E., et al (2021) Blood Advances [record in progress]

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.
Gagelmann, N., et al. (2021) Blood Advances [record in progress]

Post-Transplant Cyclophosphamide (PTCy) is Associated with Increased Cytomegalovirus Infection: A CIBMTR Analysis.
Goldsmith, S. R., et al. (2021) Blood [record in progress]

Defibrotide In Hematopoietic Stem Cell Transplantation: A Multicenter Survey Study Of The Spanish Hematopoietic Stem Cell Transplantation Group (GETH)
González Vicent, M., et al. (2021) European Journal of Haematology [record in progress]

Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler, A., et al. (2021) Cancer [record in progress]

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia.
Pierini, A., et al. (2021) Blood Advances [record in progress]

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.
Robin, M., et al. (2021) Bone Marrow Transplantation [record in progress]

Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
Shimomura, Y., et al. (2021) Bone Marrow Transplantation [record in progress]

No comments:

Post a Comment